The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1201
Topiramate (Topamax) for Prevention of Migraine
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Patients with frequent, severe or disabling migraine headaches may benefit from taking a drug to prevent the attacks. Beta-blockers traditionally have been the prophylactic treatment of choice, but in recent years some antiepileptic drugs such as valproate (Depakote, and others) and topiramate (Topamax) have also been used for this indication.Valproate was approved by the FDA for such use in 1996. Now topiramate has also been approved.

OTHER DRUGS — Propranolol and timolol are the only beta-blockers approved by the FDA for prevention of migraine, but metoprolol (Lopressor, and others), nadolol (Corgard, and others) and atenolol (Tenormin, and others) have been used as well.1 Beta-blockers can cause fatigue, exercise intolerance, depression, orthostatic hypotension and decreased libido. All are relatively contraindicated in patients ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Topiramate (Topamax) for Prevention of Migraine
Article code: 1201a
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian